Trial of Lilly schizophrenia drug inconclusive-WEB ONLY
Indianapolis-based Eli Lilly and Co.’s experimental drug for schizophrenia did not prove in its latest test that it works better than existing medication, the company announced today. The drug showed promise in an early study two years ago, but Lilly said the drug performed inconclusively in a Phase II clinical trial. The drug maker said […]